Pub Date : 2025-11-02DOI: 10.1016/j.rcsop.2025.100679
Anna Artner , Ákos Niedermüller , Máté Attila Csapó , Nikoletta Ngo Hanh , Emília Fekete , Romána Zelkó , Szilvia Sebők
Background
Off-label use of medicines raises important safety and regulatory concerns. Tamsulosin, an alpha-1 adrenergic receptor blocker originally approved for benign prostatic hyperplasia (BPH) in men, is also prescribed beyond licensed indications.
Aim
This study aimed to describe national on-label and off-label prescribing patterns of tamsulosin in Hungary using insurance and regulatory data.
Methods
We conducted a retrospective, cross-sectional descriptive analysis of two national datasets: the National Health Insurance Fund (NEAK) database of reimbursed prescriptions (2019–2023) and the National Institute of Pharmacy and Nutrition (NNGYK) records of off-label authorisations (2009–2023). Prescriptions were analyzed by sex and International Classification of Diseases 10th Revision (ICD-10) codes.
Results
A total of 906,011 prescriptions were linked to 214 ICD-10 codes; 805 entries lacked identifiable codes. Of these, 888,830 (98.1 %) were for men and 17,181 (1.9 %) for women. Female prescriptions most frequently carried codes for ureteral stones (2805; 16.3 %), dysuria (1872; 10.9 %), urinary retention (1722; 10.0 %), and kidney stones (1498; 8.7 %). Notably, 2845 prescriptions (16.6 %) in women were linked to prostate-related codes, suggesting coding errors. NNGYK approved eight individual off-label requests, mainly for urological indications.
Conclusions
Off-label tamsulosin prescribing in Hungary is relatively infrequent but concentrated in women. These findings highlight the importance of pharmacovigilance, clinician awareness, and further research to clarify its therapeutic role in non-BPH indications.
{"title":"Off-label prescribing of tamsulosin: A nationwide retrospective study combining prescription and regulatory data","authors":"Anna Artner , Ákos Niedermüller , Máté Attila Csapó , Nikoletta Ngo Hanh , Emília Fekete , Romána Zelkó , Szilvia Sebők","doi":"10.1016/j.rcsop.2025.100679","DOIUrl":"10.1016/j.rcsop.2025.100679","url":null,"abstract":"<div><h3>Background</h3><div>Off-label use of medicines raises important safety and regulatory concerns. Tamsulosin, an alpha-1 adrenergic receptor blocker originally approved for benign prostatic hyperplasia (BPH) in men, is also prescribed beyond licensed indications.</div></div><div><h3>Aim</h3><div>This study aimed to describe national on-label and off-label prescribing patterns of tamsulosin in Hungary using insurance and regulatory data.</div></div><div><h3>Methods</h3><div>We conducted a retrospective, cross-sectional descriptive analysis of two national datasets: the National Health Insurance Fund (NEAK) database of reimbursed prescriptions (2019–2023) and the National Institute of Pharmacy and Nutrition (NNGYK) records of off-label authorisations (2009–2023). Prescriptions were analyzed by sex and International Classification of Diseases 10th Revision (ICD-10) codes.</div></div><div><h3>Results</h3><div>A total of 906,011 prescriptions were linked to 214 ICD-10 codes; 805 entries lacked identifiable codes. Of these, 888,830 (98.1 %) were for men and 17,181 (1.9 %) for women. Female prescriptions most frequently carried codes for ureteral stones (2805; 16.3 %), dysuria (1872; 10.9 %), urinary retention (1722; 10.0 %), and kidney stones (1498; 8.7 %). Notably, 2845 prescriptions (16.6 %) in women were linked to prostate-related codes, suggesting coding errors. NNGYK approved eight individual off-label requests, mainly for urological indications.</div></div><div><h3>Conclusions</h3><div>Off-label tamsulosin prescribing in Hungary is relatively infrequent but concentrated in women. These findings highlight the importance of pharmacovigilance, clinician awareness, and further research to clarify its therapeutic role in non-BPH indications.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100679"},"PeriodicalIF":1.8,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145465657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-27DOI: 10.1016/j.rcsop.2025.100674
Tsegaye Melaku, Dula Dessalegn, Mestawet Getachew
Background
Access to essential medicines is a fundamental component of achieving universal health coverage, as outlined by the World Health Organization's(WHO) framework. Despite various efforts to improve access to essential medicines, there remains a gap in comprehensive data regarding their availability, price, and affordability at health facilities in Ethiopia. This systematic review and meta-analysis aimed to assess the pooled estimates of availability, price, and affordability of generic essential medicines at health facilities in Ethiopia.
Methods
We conducted a complete search of electronic databases (PubMed/MEDLINE, EMBASE, Science Direct, Web of Science, Scopus, African Index Medicus, AJOL, Google Scholar, and Organization repositories such as the Ministry of Health, Ethiopian Pharmaceuticals Supply Service) to find relevant articles on the topic from inception to August 2025. Data was analyzed using STATA version 18.0. Random-effect model meta-analysis and descriptive statistics were performed to determine the pooled availability and affordability, respectively. Statistical significance was considered at a p-value less than 0.05.
Results
A total of 46 studies, encompassing data from 2302 health facilities, were included in the final analysis. The overall mean availability of essential medicines was 63.89 % (± 19.48 SD). In public health facilities, the pooled availability was 64 % (95 % CI: 58 %–70 %), while in private facilities it was lower at 54 % (95 % CI: 42 %–66 %). The pooled proportion of unaffordable medicines was 62 % (95 % CI: 45 %–79 %). Analysis of the Median Price Ratios (MPRs) revealed that, in public health facilities, MPRs ranged from 0.55 to 5.21, with an overall median (IQR) of 1.45 (1.26–2.31). In private health facilities, MPRs ranged from 0.88 to 11.17, with a higher overall median (IQR) of 3.66 (2.12–4.10), reflecting greater price variability and reduced affordability in the private sector.
Conclusion
The availability of generic essential medicines in Ethiopia was below the WHO target of 80 % in both public and private health facilities. Prices of these medicines were higher than international reference prices, with significant variations across sectors. About two-thirds of the evaluated medicines were unaffordable. Addressing these challenges will require coordinated efforts, including policy refinement, supply chain improvements, and context-specific interventions, to progressively enhance equitable access to essential medicines across all sectors.
根据世界卫生组织(世卫组织)框架的概述,获得基本药物是实现全民健康覆盖的一个基本组成部分。尽管为改善基本药物的可及性作出了各种努力,但在埃塞俄比亚的卫生设施中,关于这些药物的可得性、价格和可负担性的综合数据仍然存在差距。本系统综述和荟萃分析旨在评估埃塞俄比亚卫生机构对非专利基本药物的可得性、价格和可负担性的综合估计。方法全面检索PubMed/MEDLINE、EMBASE、Science Direct、Web of Science、Scopus、African Index Medicus、AJOL、谷歌Scholar和组织库(Ministry of Health, Ethiopian medicines Supply Service)自成立至2025年8月的相关文章。数据分析采用STATA 18.0版本。随机效应模型荟萃分析和描述性统计分别确定了合用性和可负担性。p值小于0.05时认为具有统计学意义。结果最终分析共纳入46项研究,包括来自2302家卫生机构的数据。总体平均基本药物可获得性为63.89%(±19.48 SD)。在公共卫生设施中,综合可用性为64%(95%置信区间:58% - 70%),而在私营设施中,这一比例较低,为54%(95%置信区间:42% - 66%)。负担不起药品的总比例为62%(95%可信区间:45% - 79%)。对中位数价格比(mpr)的分析显示,在公共卫生设施中,mpr的范围为0.55至5.21,总体中位数(IQR)为1.45(1.26-2.31)。在私营保健设施中,mpr从0.88到11.17不等,总体中位数(IQR)较高,为3.66(2.12-4.10),反映出价格波动较大,私营部门的负担能力降低。结论埃塞俄比亚公立和私立卫生机构的仿制药基本药物可得性均低于世卫组织80%的目标。这些药品的价格高于国际参考价格,各部门之间差异很大。大约三分之二的评估药物是负担不起的。应对这些挑战需要协调努力,包括完善政策、改善供应链和针对具体情况的干预措施,以逐步加强所有部门公平获得基本药物的机会。系统评价注册号:PROSPERO CRD420251137000。
{"title":"The triple burden: A systematic review and meta-analysis of essential medicine availability, price, and affordability across Ethiopian health facilities","authors":"Tsegaye Melaku, Dula Dessalegn, Mestawet Getachew","doi":"10.1016/j.rcsop.2025.100674","DOIUrl":"10.1016/j.rcsop.2025.100674","url":null,"abstract":"<div><h3>Background</h3><div>Access to essential medicines is a fundamental component of achieving universal health coverage, as outlined by the World Health Organization's(WHO) framework. Despite various efforts to improve access to essential medicines, there remains a gap in comprehensive data regarding their availability, price, and affordability at health facilities in Ethiopia. This systematic review and meta-analysis aimed to assess the pooled estimates of availability, price, and affordability of generic essential medicines at health facilities in Ethiopia.</div></div><div><h3>Methods</h3><div>We conducted a complete search of electronic databases (PubMed/MEDLINE, EMBASE, Science Direct, Web of Science, Scopus, African Index Medicus, AJOL, Google Scholar, and Organization repositories such as the Ministry of Health, Ethiopian Pharmaceuticals Supply Service) to find relevant articles on the topic from inception to August 2025. Data was analyzed using STATA version 18.0. Random-effect model meta-analysis and descriptive statistics were performed to determine the pooled availability and affordability, respectively. Statistical significance was considered at a <em>p</em>-value less than 0.05.</div></div><div><h3>Results</h3><div>A total of 46 studies, encompassing data from 2302 health facilities, were included in the final analysis. The overall mean availability of essential medicines was 63.89 % (± 19.48 SD). In public health facilities, the pooled availability was 64 % (95 % CI: 58 %–70 %), while in private facilities it was lower at 54 % (95 % CI: 42 %–66 %). The pooled proportion of unaffordable medicines was 62 % (95 % CI: 45 %–79 %). Analysis of the Median Price Ratios (MPRs) revealed that, in public health facilities, MPRs ranged from 0.55 to 5.21, with an overall median (IQR) of 1.45 (1.26–2.31). In private health facilities, MPRs ranged from 0.88 to 11.17, with a higher overall median (IQR) of 3.66 (2.12–4.10), reflecting greater price variability and reduced affordability in the private sector.</div></div><div><h3>Conclusion</h3><div>The availability of generic essential medicines in Ethiopia was below the WHO target of 80 % in both public and private health facilities. Prices of these medicines were higher than international reference prices, with significant variations across sectors. About two-thirds of the evaluated medicines were unaffordable. Addressing these challenges will require coordinated efforts, including policy refinement, supply chain improvements, and context-specific interventions, to progressively enhance equitable access to essential medicines across all sectors.</div><div><strong>Systematic review registration number:</strong> PROSPERO CRD420251137000.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100674"},"PeriodicalIF":1.8,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145415759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medication reconciliation and -reviews are not emphasized in the pharmacy curriculums in Norway and graduated pharmacists are at novice level. Therefore, a postgraduate training program for hospital-based clinical pharmacists was developed. The aim of this paper is to describe the program design and evaluation of the last four years (2021–2024).
Method
The training program, established in 2012, used Southern Sweden's training in Integrated Medicines Management as inspiration. Experienced clinical pharmacists in Norway have further developed and improved the program. The training program comprises i) a three-day in-class and skill training course in a simulation lab ii) eight days in a hospital ward performing medication reconciliations and - reviews under individual supervision from a clinical supervisor, i.e. an experienced clinical pharmacist, and iii) independently conducted medication reconciliations and –reviews presented to the supervisor for feedback and reflection.
Results
Of 46 participants in the last four years, 39 (85 %) completed a questionnaire. Participants scored their overall satisfaction with a median of 6 (range 4–6) on a scale from 1 to 6. Participants highlighted the way the course is organized and facilitated by skilled lecturers, active learning with feedback, peer learning, and work relevance as positive factors.
Conclusion
A comprehensive work-integrated training program with various and active learning methods that can be used as a template in settings where pharmacists graduate at novice level in medication reconciliation and -reviews has been developed. The program is appreciated by participants, seems to improve their professional confidence, and could ensure standardised high quality clinical pharmacy services.
{"title":"Design and evaluation of a comprehensive training program for hospital-based clinical pharmacists - various, active, and work-integrated learning","authors":"Marianne Lea , Elin Trapnes , Hanne Steen , Nina Bjerketveit Ødegaard","doi":"10.1016/j.rcsop.2025.100677","DOIUrl":"10.1016/j.rcsop.2025.100677","url":null,"abstract":"<div><h3>Background</h3><div>Medication reconciliation and -reviews are not emphasized in the pharmacy curriculums in Norway and graduated pharmacists are at novice level. Therefore, a postgraduate training program for hospital-based clinical pharmacists was developed. The aim of this paper is to describe the program design and evaluation of the last four years (2021–2024).</div></div><div><h3>Method</h3><div>The training program, established in 2012, used Southern Sweden's training in Integrated Medicines Management as inspiration. Experienced clinical pharmacists in Norway have further developed and improved the program. The training program comprises i) a three-day in-class and skill training course in a simulation lab ii) eight days in a hospital ward performing medication reconciliations and - reviews under individual supervision from a clinical supervisor, i.e. an experienced clinical pharmacist, and iii) independently conducted medication reconciliations and –reviews presented to the supervisor for feedback and reflection.</div></div><div><h3>Results</h3><div>Of 46 participants in the last four years, 39 (85 %) completed a questionnaire. Participants scored their overall satisfaction with a median of 6 (range 4–6) on a scale from 1 to 6. Participants highlighted the way the course is organized and facilitated by skilled lecturers, active learning with feedback, peer learning, and work relevance as positive factors.</div></div><div><h3>Conclusion</h3><div>A comprehensive work-integrated training program with various and active learning methods that can be used as a template in settings where pharmacists graduate at novice level in medication reconciliation and -reviews has been developed. The program is appreciated by participants, seems to improve their professional confidence, and could ensure standardised high quality clinical pharmacy services.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100677"},"PeriodicalIF":1.8,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medication adherence is essential for treatment success across both chronic and acute conditions. However, concise, multidimensional, and broadly applicable validated tools to measure medication adherence remain scarce.
Objectives
This study primarily aimed to develop and validate the Short Medication Adherence Scale (SMAS-7) and, secondarily, to assess adherence levels and related factors in a general adult population.
Methods
A cross-sectional study was conducted among Lebanese adults aged ≥18 years from the general population. Individuals who declined follow-up contact for the test-retest phase were excluded. The 7-item SMAS-7, developed from the LMAS-14, was administered electronically in Arabic using an online questionnaire. Exploratory and confirmatory factor analyses (EFA and CFA) were performed on two random subsamples to assess factorial structure and model fit. Internal consistency (Cronbach's α, McDonald's ω), test-retest reliability (ICC), and construct and criterion validity were evaluated. Multivariable logistic regression identified predictors of adherence using a ROC curve-derived SMAS-7 cut-off score.
Results
A total of 501 participants were included in the study. EFA revealed a 3-factor structure, psychological, economic, and behavioral domains, supported by KMO = 0.830 and significant Bartlett's test (P < 0.001). CFA confirmed the structure with excellent fit (χ2/df = 1.757, CFI = 0.992, TLI = 0.985, RMSEA = 0.055, SRMR = 0.020). The SMAS-7 demonstrated high internal consistency (α = 0.889, ω = 0.945) and test-retest reliability (ICC = 0.779). Criterion validity was excellent (AUC = 0.985; sensitivity = 91.2 %; specificity = 96.0 %). Suboptimal adherence was observed in 52.3 % of participants. Significant predictors of adherence included gender (P = 0.030), region (P = 0.014), financial well-being (P = 0.002), chronic illness (P = 0.009), communication barriers (P = 0.013), and patient perception (P = 0.029).
Conclusion
The SMAS-7 demonstrated strong preliminary psychometric properties in this initial validation study. It offers a valuable resource for researchers, clinicians, and policymakers seeking to monitor and enhance adherence behaviors. While these findings are encouraging, further studies in diverse populations and clinical settings are required to confirm its external validity and generalizability. The findings revealed suboptimal adherence and underscored the multifaceted nature of its predictors, highlighting the need for targeted, multidimensional interventions.
{"title":"The short medication adherence scale (SMAS-7): Development and psychometric validation in a general population sample","authors":"Fouad Sakr , Mariam Dabbous , Jihan Safwan , Mohamad Rahal , Pascale Salameh","doi":"10.1016/j.rcsop.2025.100676","DOIUrl":"10.1016/j.rcsop.2025.100676","url":null,"abstract":"<div><h3>Background</h3><div>Medication adherence is essential for treatment success across both chronic and acute conditions. However, concise, multidimensional, and broadly applicable validated tools to measure medication adherence remain scarce.</div></div><div><h3>Objectives</h3><div>This study primarily aimed to develop and validate the Short Medication Adherence Scale (SMAS-7) and, secondarily, to assess adherence levels and related factors in a general adult population.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted among Lebanese adults aged ≥18 years from the general population. Individuals who declined follow-up contact for the test-retest phase were excluded. The 7-item SMAS-7, developed from the LMAS-14, was administered electronically in Arabic using an online questionnaire. Exploratory and confirmatory factor analyses (EFA and CFA) were performed on two random subsamples to assess factorial structure and model fit. Internal consistency (Cronbach's α, McDonald's ω), test-retest reliability (ICC), and construct and criterion validity were evaluated. Multivariable logistic regression identified predictors of adherence using a ROC curve-derived SMAS-7 cut-off score.</div></div><div><h3>Results</h3><div>A total of 501 participants were included in the study. EFA revealed a 3-factor structure, psychological, economic, and behavioral domains, supported by KMO = 0.830 and significant Bartlett's test (<em>P</em> < 0.001). CFA confirmed the structure with excellent fit (χ<sup>2</sup>/df = 1.757, CFI = 0.992, TLI = 0.985, RMSEA = 0.055, SRMR = 0.020). The SMAS-7 demonstrated high internal consistency (α = 0.889, ω = 0.945) and test-retest reliability (ICC = 0.779). Criterion validity was excellent (AUC = 0.985; sensitivity = 91.2 %; specificity = 96.0 %). Suboptimal adherence was observed in 52.3 % of participants. Significant predictors of adherence included gender (<em>P</em> = 0.030), region (<em>P</em> = 0.014), financial well-being (<em>P</em> = 0.002), chronic illness (<em>P</em> = 0.009), communication barriers (<em>P</em> = 0.013), and patient perception (<em>P</em> = 0.029).</div></div><div><h3>Conclusion</h3><div>The SMAS-7 demonstrated strong preliminary psychometric properties in this initial validation study. It offers a valuable resource for researchers, clinicians, and policymakers seeking to monitor and enhance adherence behaviors. While these findings are encouraging, further studies in diverse populations and clinical settings are required to confirm its external validity and generalizability. The findings revealed suboptimal adherence and underscored the multifaceted nature of its predictors, highlighting the need for targeted, multidimensional interventions.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100676"},"PeriodicalIF":1.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145415761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-24DOI: 10.1016/j.rcsop.2025.100672
Hazzaa Alghamdi , Talal S. Alshihayb , Yazeed Alharbi , Mohammad Alawagi , Abdullah Aleissa , Yasser Albogami
Background
Operational efficiency in outpatient pharmacies is a critical factor in healthcare delivery, directly impacting patient satisfaction and adherence to prescribed treatments. Prolonged waiting times in pharmacies can lead to patient dissatisfaction, reduced medication adherence, and potential health risks.
Objective
This study aimed to analyze the impact of a data-driven intervention on reducing patient waiting times in an outpatient pharmacy at a tertiary hospital, with a goal of ensuring that patients are served within 30 min of ticket issuance.
Methods
The study utilized data from the “Qsmart” ticketing system, covering October 2022 to November 2023. A descriptive analysis was conducted to identify peak service hours and assess staffing patterns. An interrupted time series analysis (ITSA) was employed to evaluate the effectiveness of an intervention implemented between January 22 and February 26, 2023. The intervention included increased staffing during peak hours, adjustments to break schedules, and enhanced pre-peak hour preparations.
Results
The descriptive analysis revealed peak service hours between 9 AM and 11 AM, with the highest number of tickets issued at 10 AM. The intervention produced a significant immediate level reduction in waiting times of 0.1540 (95 %CI: 0.0421,0.2659) but there was no additional post-intervention slope change, indicating that the improvement was not progressively increasing over time.
Conclusion
The data-driven intervention effectively reduced waiting times in the outpatient pharmacy, with significant immediate improvements observed. This study highlights the potential of strategic operational adjustments to enhance service efficiency and patient satisfaction. Further research is needed to validate the sustainability and generalizability of these findings in other settings.
{"title":"A data-driven approach to optimizing waiting times in outpatient pharmacy services: Interrupted time series analysis","authors":"Hazzaa Alghamdi , Talal S. Alshihayb , Yazeed Alharbi , Mohammad Alawagi , Abdullah Aleissa , Yasser Albogami","doi":"10.1016/j.rcsop.2025.100672","DOIUrl":"10.1016/j.rcsop.2025.100672","url":null,"abstract":"<div><h3>Background</h3><div>Operational efficiency in outpatient pharmacies is a critical factor in healthcare delivery, directly impacting patient satisfaction and adherence to prescribed treatments. Prolonged waiting times in pharmacies can lead to patient dissatisfaction, reduced medication adherence, and potential health risks.</div></div><div><h3>Objective</h3><div>This study aimed to analyze the impact of a data-driven intervention on reducing patient waiting times in an outpatient pharmacy at a tertiary hospital, with a goal of ensuring that patients are served within 30 min of ticket issuance.</div></div><div><h3>Methods</h3><div>The study utilized data from the “Qsmart” ticketing system, covering October 2022 to November 2023. A descriptive analysis was conducted to identify peak service hours and assess staffing patterns. An interrupted time series analysis (ITSA) was employed to evaluate the effectiveness of an intervention implemented between January 22 and February 26, 2023. The intervention included increased staffing during peak hours, adjustments to break schedules, and enhanced pre-peak hour preparations.</div></div><div><h3>Results</h3><div>The descriptive analysis revealed peak service hours between 9 AM and 11 AM, with the highest number of tickets issued at 10 AM. The intervention produced a significant immediate level reduction in waiting times of 0.1540 (95 %CI: 0.0421,0.2659) but there was <strong>no additional post-intervention slope change</strong>, indicating that the improvement was not progressively increasing over time.</div></div><div><h3>Conclusion</h3><div>The data-driven intervention effectively reduced waiting times in the outpatient pharmacy, with significant immediate improvements observed. This study highlights the potential of strategic operational adjustments to enhance service efficiency and patient satisfaction. Further research is needed to validate the sustainability and generalizability of these findings in other settings.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100672"},"PeriodicalIF":1.8,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145465616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-24DOI: 10.1016/j.rcsop.2025.100678
Anna K. Moritz , Wolfgang Fehrmann , Markus K. Schuler , Stephanie Stock , Ulrich Jaehde , Nicole Ernstmann
Background
The increasing use of oral anticancer therapy (OAT) requires self-management skills from cancer patients. Adequate information and counseling, as well as medication literacy, are key elements of safe and successful therapy in the patient's home.
Objective
The aim of the study was to identify unmet information needs and knowledge gaps of cancer patients regarding their therapy with OAT.
Methods
Semi-structured, guideline-based interviews with cancer patients undergoing OAT were conducted, recorded and professionally transcribed. The transcripts were analysed using qualitative content analysis.
Results
A total of 21 interviews were conducted. Fifteen of the interviewees were female, the median age was 69.6 years. Patients with solid tumours as well as those with blood cancers were interviewed. In the interviews, experiences were reported with various classes of OATs (chemotherapy; anti-hormonal therapy; targeted therapy). The following themes were identified: 1) Therapy-related information needs; 2) No information received; 3) No awareness for information needs; 4) No need for more information; 5) Therapy-related knowledge gaps; 6) Potentially inadequate knowledge. Deficits were identified in relation to correct use, possible interactions, and dealing with adverse events. Individual patients also report actively avoiding information.
Conclusion
The identified information needs and knowledge gaps of patients undergoing OAT highlight the need to optimize information and counseling in order to ensure treatment safety and success. In addition to providing knowledge, the self-management skills of patients should also be specifically strengthened. Furthermore, improvements to the structural framework in the outpatient setting are necessary, particularly with regard to the availability of counseling services. The results can be used as a basis for the development of specific interprofessional educational interventions for those affected.
{"title":"Unmet information needs and knowledge gaps in cancer patients undergoing oral anticancer therapy","authors":"Anna K. Moritz , Wolfgang Fehrmann , Markus K. Schuler , Stephanie Stock , Ulrich Jaehde , Nicole Ernstmann","doi":"10.1016/j.rcsop.2025.100678","DOIUrl":"10.1016/j.rcsop.2025.100678","url":null,"abstract":"<div><h3>Background</h3><div>The increasing use of oral anticancer therapy (OAT) requires self-management skills from cancer patients. Adequate information and counseling, as well as medication literacy, are key elements of safe and successful therapy in the patient's home.</div></div><div><h3>Objective</h3><div>The aim of the study was to identify unmet information needs and knowledge gaps of cancer patients regarding their therapy with OAT.</div></div><div><h3>Methods</h3><div>Semi-structured, guideline-based interviews with cancer patients undergoing OAT were conducted, recorded and professionally transcribed. The transcripts were analysed using qualitative content analysis.</div></div><div><h3>Results</h3><div>A total of 21 interviews were conducted. Fifteen of the interviewees were female, the median age was 69.6 years. Patients with solid tumours as well as those with blood cancers were interviewed. In the interviews, experiences were reported with various classes of OATs (chemotherapy; anti-hormonal therapy; targeted therapy). The following themes were identified: 1) Therapy-related information needs; 2) No information received; 3) No awareness for information needs; 4) No need for more information; 5) Therapy-related knowledge gaps; 6) Potentially inadequate knowledge. Deficits were identified in relation to correct use, possible interactions, and dealing with adverse events. Individual patients also report actively avoiding information.</div></div><div><h3>Conclusion</h3><div>The identified information needs and knowledge gaps of patients undergoing OAT highlight the need to optimize information and counseling in order to ensure treatment safety and success. In addition to providing knowledge, the self-management skills of patients should also be specifically strengthened. Furthermore, improvements to the structural framework in the outpatient setting are necessary, particularly with regard to the availability of counseling services. The results can be used as a basis for the development of specific interprofessional educational interventions for those affected.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100678"},"PeriodicalIF":1.8,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145465617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-24DOI: 10.1016/j.rcsop.2025.100673
David A. Mott , William R. Doucette , Eilan Alhersh , Vibhuti Arya , Brianne K. Bakken , Caroline Gaither , David H. Kreling , Jon C. Schommer , Matthew Witry
Background
Overemployment and underemployment are associated with fluctuations in labor supply and can negatively impact psychosocial aspects of work and worker health.
Objectives
The objectives of this study were to 1) determine the prevalence and characteristics of underemployment, overemployment and matched employment among part-time pharmacists; 2) examine differences in actual and ideal hours worked for overemployed and underemployed part-time pharmacists; and 3) test associations between overemployment, underemployment and matched employment and part-time pharmacists' perceptions of job quality and work-life characteristics.
Methods
Data for 636 pharmacists self-reporting working part-time (≤ 30 h/week) were extracted from the 2019 National Pharmacists Workforce Study. The difference in self-reported actual and ideal hours worked weekly was calculated and used to classify part-time pharmacists as overemployed, underemployed or matched employed. Differences between the variables were tested with multivariate ordinary least squares regression models.
Results
Being matched employed was most common (41.3 %) followed by underemployed (34.9 %) and being overemployed (23.8 %). Of underemployed respondents, over half (54.1 %) reported wanting to work full-time, which likely is reflective of the relatively loose national pharmacist labor market in 2019. Overemployed and underemployed respondents reported significantly lower levels of several of the work-life characteristics relative to those with matched employment.
Conclusion
The higher rate of underemployment among pharmacists working part-time is consistent with the surplus of US pharmacists in 2019. The results show that for pharmacists working part-time, a lack of control over how much they work is negatively associated with job quality and work-life characteristics relative to pharmacists with work schedule control.
{"title":"Overemployment and underemployment of part-time pharmacists: Prevalence and connection to work-life characteristics","authors":"David A. Mott , William R. Doucette , Eilan Alhersh , Vibhuti Arya , Brianne K. Bakken , Caroline Gaither , David H. Kreling , Jon C. Schommer , Matthew Witry","doi":"10.1016/j.rcsop.2025.100673","DOIUrl":"10.1016/j.rcsop.2025.100673","url":null,"abstract":"<div><h3>Background</h3><div>Overemployment and underemployment are associated with fluctuations in labor supply and can negatively impact psychosocial aspects of work and worker health.</div></div><div><h3>Objectives</h3><div>The objectives of this study were to 1) determine the prevalence and characteristics of underemployment, overemployment and matched employment among part-time pharmacists; 2) examine differences in actual and ideal hours worked for overemployed and underemployed part-time pharmacists; and 3) test associations between overemployment, underemployment and matched employment and part-time pharmacists' perceptions of job quality and work-life characteristics.</div></div><div><h3>Methods</h3><div>Data for 636 pharmacists self-reporting working part-time (≤ 30 h/week) were extracted from the 2019 National Pharmacists Workforce Study. The difference in self-reported actual and ideal hours worked weekly was calculated and used to classify part-time pharmacists as overemployed, underemployed or matched employed. Differences between the variables were tested with multivariate ordinary least squares regression models.</div></div><div><h3>Results</h3><div>Being matched employed was most common (41.3 %) followed by underemployed (34.9 %) and being overemployed (23.8 %). Of underemployed respondents, over half (54.1 %) reported wanting to work full-time, which likely is reflective of the relatively loose national pharmacist labor market in 2019. Overemployed and underemployed respondents reported significantly lower levels of several of the work-life characteristics relative to those with matched employment.</div></div><div><h3>Conclusion</h3><div>The higher rate of underemployment among pharmacists working part-time is consistent with the surplus of US pharmacists in 2019. The results show that for pharmacists working part-time, a lack of control over how much they work is negatively associated with job quality and work-life characteristics relative to pharmacists with work schedule control.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100673"},"PeriodicalIF":1.8,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145415762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Irrational drug use remains a global health challenge, particularly in underserved communities with limited healthcare access. In Thailand, despite the Rational Drug Use (RDU) initiative, problems such as antibiotic misuse and selfmedication persist. Rational Drug Use Literacy (RDUL)—the ability to access, understand, evaluate, and apply drug information—is vital for improving medication behaviors. While most efforts focus on health professionals, the role of community leaders has been less explored.
Methods
A cross-sectional study was conducted with 328 participants in Pathum Thani Province, including 168 community members and 160 community leaders selected through stratified random sampling. Data were collected using a structured questionnaire and a validated RDUL tool. Structural Equation Modeling (PLS-SEM) was used to assess direct and moderating effects of situational and socioenvironmental factors on RDUL.
Results
Community leaders exhibited higher Rational Drug Use Literacy (RDUL) than community members (M = 41.90 vs. 39.48, p = .003), particularly in accessing, appraising, and applying drug information. Structural Equation Modeling revealed that both situational factors (β = 0.357, p < .001) and socio-environmental factors (β = 0.168, p = .021) positively influenced RDUL, indicating that favorable circumstances and supportive environments enhance individuals' medication literacy. Importantly, leadership played a nuanced role: it diminished the influence of situational factors on RDUL (β = −0.634, p < .001) while moderately amplifying the effect of socioenvironmental factors (β = 0.327, p = .058). These results highlight that community leaders not only enhance overall medication literacy but also alter how contextual factors contribute to informed drug use.
Conclusions
Community leaders play a complex but crucial role in shaping RDUL. While they strengthen certain literacy dimensions, their influence also alters contextual effects. RDUL strategies should leverage leaders as trusted figures while enhancing their capacity to promote informed medication use. Incorporating community leadership into health programs may increase the effectiveness and sustainability of RDU efforts in resource-limited settings.
背景:不合理用药仍然是一项全球卫生挑战,特别是在医疗服务不足、可及性有限的社区。在泰国,尽管实施了合理用药(RDU)倡议,但抗生素滥用和自我用药等问题仍然存在。合理用药素养(RDUL)——获取、理解、评估和应用药物信息的能力——对改善用药行为至关重要。虽然大多数努力的重点是卫生专业人员,但对社区领导人的作用的探索较少。方法采用分层随机抽样的方法,对巴吞他尼省328名被试进行横断面研究,其中168名社区成员和160名社区领导。使用结构化问卷和经过验证的RDUL工具收集数据。采用结构方程模型(PLS-SEM)评估情境因素和社会环境因素对RDUL的直接和调节作用。结果社区领导的合理用药素养(RDUL)高于社区成员(M = 41.90 vs. 39.48, p = 0.003),特别是在获取、评价和应用药物信息方面。结构方程模型显示,情境因素(β = 0.357, p < .001)和社会环境因素(β = 0.168, p = 0.021)对RDUL均有正向影响,说明良好的环境和支持性环境提高了个体的用药素养。重要的是,领导发挥了微妙的作用:它降低了情境因素对RDUL的影响(β = - 0.634, p < .001),而适度放大了社会环境因素的影响(β = 0.327, p = 0.058)。这些结果强调,社区领导人不仅提高了整体的药物素养,而且还改变了环境因素对知情用药的影响。社区领导在RDUL的形成中起着复杂但至关重要的作用。在加强某些识字维度的同时,它们的影响也改变了语境效应。RDUL战略应利用领导者作为可信赖的人物,同时增强他们促进知情用药的能力。在资源有限的情况下,将社区领导纳入卫生计划可以提高RDU工作的有效性和可持续性。
{"title":"The role of community leaders on rational drug use literacy: A structural equation modeling","authors":"Thunpitcha Sakpirom , Kusawadee Maluangnon , Chaoncin Sooksriwong , Apinya Ingard","doi":"10.1016/j.rcsop.2025.100675","DOIUrl":"10.1016/j.rcsop.2025.100675","url":null,"abstract":"<div><h3>Background</h3><div>Irrational drug use remains a global health challenge, particularly in underserved communities with limited healthcare access. In Thailand, despite the Rational Drug Use (RDU) initiative, problems such as antibiotic misuse and selfmedication persist. Rational Drug Use Literacy (RDUL)—the ability to access, understand, evaluate, and apply drug information—is vital for improving medication behaviors. While most efforts focus on health professionals, the role of community leaders has been less explored.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted with 328 participants in Pathum Thani Province, including 168 community members and 160 community leaders selected through stratified random sampling. Data were collected using a structured questionnaire and a validated RDUL tool. Structural Equation Modeling (PLS-SEM) was used to assess direct and moderating effects of situational and socioenvironmental factors on RDUL.</div></div><div><h3>Results</h3><div>Community leaders exhibited higher Rational Drug Use Literacy (RDUL) than community members (M = 41.90 vs. 39.48, <em>p</em> = .003), particularly in accessing, appraising, and applying drug information. Structural Equation Modeling revealed that both situational factors (β = 0.357, <em>p</em> < .001) and socio-environmental factors (β = 0.168, <em>p</em> = .021) positively influenced RDUL, indicating that favorable circumstances and supportive environments enhance individuals' medication literacy. Importantly, leadership played a nuanced role: it diminished the influence of situational factors on RDUL (β = −0.634, <em>p</em> < .001) while moderately amplifying the effect of socioenvironmental factors (β = 0.327, <em>p</em> = .058). These results highlight that community leaders not only enhance overall medication literacy but also alter how contextual factors contribute to informed drug use.</div></div><div><h3>Conclusions</h3><div>Community leaders play a complex but crucial role in shaping RDUL. While they strengthen certain literacy dimensions, their influence also alters contextual effects. RDUL strategies should leverage leaders as trusted figures while enhancing their capacity to promote informed medication use. Incorporating community leadership into health programs may increase the effectiveness and sustainability of RDU efforts in resource-limited settings.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100675"},"PeriodicalIF":1.8,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145415760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Insulin therapy is crucial for Type 1 and advanced Type 2 diabetes management. Despite the convenience of insulin pens, improper use persists due to limited patient education. Pharmacists' expertise in counseling and medication safety uniquely positions them to address these gaps through individualized guidance on use, adherence, and monitoring.
Objectives
This study aimed to evaluate the impact of pharmacist-led interventions on improving insulin injection practices among diabetes patients.
Methods
A pre–post interventional study was conducted at Dhulikhel Hospital (April–September 2018) among 81 consecutively enrolled insulin pen users (≥12 years; on pens ≥2 weeks) from inpatient and outpatient wards. Patients underwent baseline assessment of 16 injection technique elements, received one-to-one pharmacist-led training with demonstration, and were reassessed immediately and after 2 weeks. The primary outcome was the total technique score (0–16), analyzed using Friedman's test and Wilcoxon signed-rank test.
Results
Cold chain maintenance was suboptimal, with 51.9 % of patients transporting insulin cartridges without an icepack. Unsafe needle disposal was common, with 40.7 % discarding needles in municipal vehicles, 13.6 % in bushes, and 4.9 % in rivers. Pharmacist-led interventions significantly improved all practices (p < 0.05). Proper cartridge storage increased from 77.8 % pre-intervention to 91.4 % post-intervention and 88.6 % at two weeks. Correct room temperature pen storage rose from 49.4 % to 95.1 % post-intervention, declining slightly to 70.8 % at two weeks. Correct insulin mixing surged from 7.8 % to 100 % post-intervention, remaining at 81.1 % at two weeks. Injection technique scores significantly improved (median pre = 10, post = 15) and were largely sustained (median two-weeks = 14).
Conclusion
Pharmacist-led education significantly improved insulin injection techniques. Integrating pharmacists into routine diabetes care and reinforcing education is essential to sustain these improvements. These findings underscore that clinical pharmacy interventions make a tangible difference in improving healthcare outcomes.
{"title":"Assessment of insulin pen injection practices and the effectiveness of pharmacist interventions in improving injection technique among patients with diabetes mellitus","authors":"Bidur Sharma , Devindra Kumar Neupane , Rahi Bikram Thapa , Rajani Shakya , Rojeena Koju Shrestha , Pooja Rimal","doi":"10.1016/j.rcsop.2025.100671","DOIUrl":"10.1016/j.rcsop.2025.100671","url":null,"abstract":"<div><h3>Background</h3><div>Insulin therapy is crucial for Type 1 and advanced Type 2 diabetes management. Despite the convenience of insulin pens, improper use persists due to limited patient education. Pharmacists' expertise in counseling and medication safety uniquely positions them to address these gaps through individualized guidance on use, adherence, and monitoring.</div></div><div><h3>Objectives</h3><div>This study aimed to evaluate the impact of pharmacist-led interventions on improving insulin injection practices among diabetes patients.</div></div><div><h3>Methods</h3><div>A pre–post interventional study was conducted at Dhulikhel Hospital (April–September 2018) among 81 consecutively enrolled insulin pen users (≥12 years; on pens ≥2 weeks) from inpatient and outpatient wards. Patients underwent baseline assessment of 16 injection technique elements, received one-to-one pharmacist-led training with demonstration, and were reassessed immediately and after 2 weeks. The primary outcome was the total technique score (0–16), analyzed using Friedman's test and Wilcoxon signed-rank test.</div></div><div><h3>Results</h3><div>Cold chain maintenance was suboptimal, with 51.9 % of patients transporting insulin cartridges without an icepack. Unsafe needle disposal was common, with 40.7 % discarding needles in municipal vehicles, 13.6 % in bushes, and 4.9 % in rivers. Pharmacist-led interventions significantly improved all practices (<em>p</em> < 0.05). Proper cartridge storage increased from 77.8 % pre-intervention to 91.4 % post-intervention and 88.6 % at two weeks. Correct room temperature pen storage rose from 49.4 % to 95.1 % post-intervention, declining slightly to 70.8 % at two weeks. Correct insulin mixing surged from 7.8 % to 100 % post-intervention, remaining at 81.1 % at two weeks. Injection technique scores significantly improved (median pre = 10, post = 15) and were largely sustained (median two-weeks = 14).</div></div><div><h3>Conclusion</h3><div>Pharmacist-led education significantly improved insulin injection techniques. Integrating pharmacists into routine diabetes care and reinforcing education is essential to sustain these improvements. These findings underscore that clinical pharmacy interventions make a tangible difference in improving healthcare outcomes.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100671"},"PeriodicalIF":1.8,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145319930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medication errors are more likely to occur in patients with complex conditions, where appropriate prescribing requires accurate and comprehensive patient information. Inadequate use of such information, such as overlooking laboratory results or patient weight, can lead to dosing errors or contraindicated prescriptions, even with electronic checking systems. This study aimed to analyze prescribing errors detected through pharmaceutical interventions, focusing on the patient information in the hospital information system.
Methods
A retrospective analysis was conducted on 9774 pharmaceutical interventions performed between April 2019 and March 2020. Of these, 3372 interventions related to patient information stored in hospital information system were included. Prescribing errors were categorized into five patient-specific information categories: allergy information, laboratory data, concomitant drugs, patient weight, and patient status and history. Demographic and prescription data were analyzed, and a heatmap was developed to visualize high-risk areas.
Results
Among the included interventions, 1352 (40.1 %) prescriptions involved corrections of prescribing errors, with laboratory data being the most frequently utilized patient information source (n = 2526). Error rates were higher in weekend settings compared to weekday settings (56.2 % vs. 38.3 %, P < 0.001, Cramér's V = 0.111), and prescriptions for patients younger than 20 years exhibited the highest error rates among age groups (66.9 %; P < 0.001). Error rates were significantly varied by drug type (P < 0.001, Cramér's V = 0.395). Among these, digestive drugs showed the highest error rates (69.1 %), particularly those requiring renal dosing adjustments. Conversely, anti-tumor agents demonstrated a lower error rate (15.9 %) due to stringent monitoring processes. The high-risk heatmap highlighted specific risks, such as weight data for younger patients and patient status for anti-inflammatory drugs.
Conclusion
Laboratory data were the most frequently used information source, to prevent prescribing errors. The risk heatmap demonstrated weekends, pediatric patients, and renal dosing as high-risk areas. These findings suggest that future information systems should enhance the utility of laboratory data and incorporate tailored alerting strategies focused on high-risk patient conditions and clinical settings, such as real-time lab data alerts or weight-based dosing calculators, and potentially explore the use of AI for proactive error prevention.
背景:在病情复杂的患者中更容易发生用药错误,在这种情况下,适当的处方需要准确和全面的患者信息。对这些信息的使用不当,例如忽视实验室结果或患者体重,即使使用电子检查系统,也可能导致剂量错误或处方禁忌。本研究旨在分析通过药物干预发现的处方错误,重点关注医院信息系统中的患者信息。方法对2019年4月至2020年3月实施的9774例药物干预进行回顾性分析。其中,3372项干预措施与存储在医院信息系统中的患者信息有关。处方错误被分为五类患者特定信息:过敏信息、实验室数据、伴随药物、患者体重、患者状态和病史。对人口统计和处方数据进行了分析,并制作了一张热图,将高风险地区可视化。结果在纳入的干预措施中,有1352张(40.1%)处方涉及处方错误纠正,其中实验室数据是最常用的患者信息源(n = 2526)。与工作日设置相比,周末设置的错误率更高(56.2% vs. 38.3%, P < 0.001, cramamer’s V = 0.111), 20岁以下患者的处方在各年龄组中错误率最高(66.9%;P < 0.001)。不同药物类型的错误率差异有统计学意义(P < 0.001, cramims’s V = 0.395)。其中,消化药物的错误率最高(69.1%),特别是那些需要肾脏剂量调整的药物。相反,由于严格的监测过程,抗肿瘤药物的错误率较低(15.9%)。高风险热图突出了特定的风险,如年轻患者的体重数据和抗炎药物的患者状态。结论实验室数据是最常用的信息来源,可有效防止处方错误。风险热图显示,周末、儿科患者和肾脏给药是高危区域。这些发现表明,未来的信息系统应增强实验室数据的效用,并结合针对高风险患者状况和临床环境的量身定制的警报策略,如实时实验室数据警报或基于体重的剂量计算器,并可能探索使用人工智能进行主动错误预防。
{"title":"The impact of patient information on prescribing errors: Insights from pharmaceutical interventions","authors":"Daisuke Koike , Masahiro Ito , Keiko Tomomatsu , Ryuta Shindo , Terumi Miyashita , Junichi Yamakami , Akihiko Horiguchi , Shigeki Yamada","doi":"10.1016/j.rcsop.2025.100665","DOIUrl":"10.1016/j.rcsop.2025.100665","url":null,"abstract":"<div><h3>Background</h3><div>Medication errors are more likely to occur in patients with complex conditions, where appropriate prescribing requires accurate and comprehensive patient information. Inadequate use of such information, such as overlooking laboratory results or patient weight, can lead to dosing errors or contraindicated prescriptions, even with electronic checking systems. This study aimed to analyze prescribing errors detected through pharmaceutical interventions, focusing on the patient information in the hospital information system.</div></div><div><h3>Methods</h3><div>A retrospective analysis was conducted on 9774 pharmaceutical interventions performed between April 2019 and March 2020. Of these, 3372 interventions related to patient information stored in hospital information system were included. Prescribing errors were categorized into five patient-specific information categories: allergy information, laboratory data, concomitant drugs, patient weight, and patient status and history. Demographic and prescription data were analyzed, and a heatmap was developed to visualize high-risk areas.</div></div><div><h3>Results</h3><div>Among the included interventions, 1352 (40.1 %) prescriptions involved corrections of prescribing errors, with laboratory data being the most frequently utilized patient information source (<em>n</em> = 2526). Error rates were higher in weekend settings compared to weekday settings (56.2 % vs. 38.3 %, <em>P</em> < 0.001, Cramér's V = 0.111), and prescriptions for patients younger than 20 years exhibited the highest error rates among age groups (66.9 %; <em>P</em> < 0.001). Error rates were significantly varied by drug type (P < 0.001, Cramér's V = 0.395). Among these, digestive drugs showed the highest error rates (69.1 %), particularly those requiring renal dosing adjustments. Conversely, anti-tumor agents demonstrated a lower error rate (15.9 %) due to stringent monitoring processes. The high-risk heatmap highlighted specific risks, such as weight data for younger patients and patient status for anti-inflammatory drugs.</div></div><div><h3>Conclusion</h3><div>Laboratory data were the most frequently used information source, to prevent prescribing errors. The risk heatmap demonstrated weekends, pediatric patients, and renal dosing as high-risk areas. These findings suggest that future information systems should enhance the utility of laboratory data and incorporate tailored alerting strategies focused on high-risk patient conditions and clinical settings, such as real-time lab data alerts or weight-based dosing calculators, and potentially explore the use of AI for proactive error prevention.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"20 ","pages":"Article 100665"},"PeriodicalIF":1.8,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}